Sara Y. Tartof, PhD MPH

Epidemiologist/Research Scientist I
Kaiser Permanente Southern California

Disclosure(s): Pfizer: Grant/Research Support; Spero: Grant/Research Support

Poster(s):

• 2232 - Association between Inappropriate Empiric Therapy (IET) and 30-Day Emergency Department/Inpatient (ED/IP) Visits Among Adult Outpatients (OPs) with Complicated Urinary Tract Infections (cUTIs)
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2233 - Clinical Risk Scores (CRSs) to Predict Resistance to Trimethoprim-Sulfamethoxazole (TMP-SMX), Fluoroquinolone (FQ), Nitrofurantoin (NIT), or Third Generation Cephalosporins (3GC) among Adult Outpatients (OPs) with Complicated Urinary Tract Infections (cUTIs)
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET